Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS* Study
2003 · Histopathology · 121 citations
https://doi.org/10.1046/j.1365-2559.2003.01598.x
P
Pascal Roger
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
178
Papers
4.3K
Citations
40
h-index
74
i10-index
Pascal Roger is an academic researcher from Inserm. The author has contributed to research in topics: Pituitary Gland Disorders and Treatments & Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research. The author has an h-index of 40, co-authored 152 publications.
ORCID: 0000-0002-4040-5892Papers by this author
worksA 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment
2021 · Theranostics · 53 citations
https://doi.org/10.7150/thno.58254
High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: A multicentre GEFPICS study
2006 · European Journal of Cancer · 51 citations
https://doi.org/10.1016/j.ejca.2006.06.020
Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH)
2012 · Modern Pathology · 50 citations
https://doi.org/10.1038/modpathol.2011.201
Mise à jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France
2014 · Annales de Pathologie · 50 citations
https://doi.org/10.1016/j.annpat.2014.08.018
Mise à jour des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France
2010 · Annales de Pathologie · 29 citations
https://doi.org/10.1016/j.annpat.2010.07.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat